{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:22:02Z","timestamp":1787772122649,"version":"build-2784847793"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Alopecia areata (AA) is a chronic, immune-mediated disorder characterized by nonscarring hair loss. Emerging evidence suggests that AA is associated with systemic inflammation, metabolic dysregulation, and coagulation abnormalities. However, data on these associations in the Indian population remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim and Objectives:<\/jats:title>\n                    <jats:p>To evaluate coagulation parameters, metabolic profiles, and inflammatory markers in Indian patients with AA and assess their correlation with disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>A case-control study was conducted at a tertiary care center in North India, including 110 AA patients and 110 age- and sex-matched healthy controls. Coagulation parameters (D-dimer, fibrinogen, prothrombin time, and activated partial thromboplastin time), metabolic markers [fasting blood glucose, lipid profile, body mass index (BMI)], and inflammatory markers [C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR)] were analyzed. Disease severity was assessed using the Severity of Alopecia Tool (SALT) score. Correlation and multivariate regression analyses were performed to identify predictors of severe AA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      AA patients exhibited significantly elevated D-dimer (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and fibrinogen levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) compared to controls, indicating a hypercoagulable state. The prothrombin time was also prolonged (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03). Metabolic abnormalities, including higher fasting blood glucose (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and total cholesterol (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.008), were observed. Inflammatory markers (CRP and ESR) were significantly elevated in AA patients. A strong positive correlation was found between SALT scores and D-dimer levels (r = 0.64,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Multivariate regression analysis identified D-dimer (95% CI: 1.58\u20134.20), fibrinogen (95% CI: 1.41\u20133.11), CRP (95% CI: 1.23\u20132.97), and BMI (95% CI: 1.18\u20132.46) as independent predictors of severe AA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations:<\/jats:title>\n                    <jats:p>Cross-sectional study design and lack of longitudinal follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Indian AA patients exhibit significant coagulation abnormalities, metabolic dysregulation, and systemic inflammation, with these factors correlating with disease severity. These findings suggest that AA extends beyond a localized dermatological disorder and may have systemic implications. These associations imply a link rather than causality due to the cross-sectional nature of the study. Further research is warranted to explore the role of targeted therapies in mitigating these risks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/idoj.idoj_352_25","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:01:39Z","timestamp":1781701299000},"page":"526-531","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Vascular and Metabolic Face of Alopecia Areata: Insights from an Indian Cohort"],"prefix":"10.4103","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1054-1738","authenticated-orcid":false,"given":"Sharang","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Dermatology, Civil Hospital, Nabha, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3379-8923","authenticated-orcid":false,"given":"Dimple","family":"Chopra","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Government Medical College, Patiala, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"R1-20260629","doi-asserted-by":"crossref","first-page":"e70182","DOI":"10.1002\/mco2.70182","article-title":"Alopecia areata: Pathogenesis, diagnosis, and therapies","volume":"6","author":"Ma","year":"2025","journal-title":"MedComm (2020)"},{"key":"R2-20260629","first-page":"397","article-title":"Epidemiology and burden of alopecia areata: A systematic review","volume":"8","author":"Villasante Fricke","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"R3-20260629","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/jid.2013.464","article-title":"Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009","volume":"134","author":"Mirzoyev","year":"2014","journal-title":"J Invest Dermatol"},{"key":"R4-20260629","first-page":"588","article-title":"Coagulation status in patients with alopecia areata: A cross-sectional study","volume":"156","author":"Shakoei","year":"2021","journal-title":"Ital J Dermatol Venerol"},{"key":"R5-20260629","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/ced.15206","article-title":"Patients with alopecia areata are at risk of endothelial dysfunction: Results of a case-control study","volume":"47","author":"Wa\u015bkiel-Burnat","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"R6-20260629","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: Epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R7-20260629","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/ijt.ijt_89_21","article-title":"A Study of correlation of alopecia areata and metabolic syndrome in northwest Indian population: A case-control study","volume":"15","author":"Singdia","year":"2023","journal-title":"Int J Trichology"},{"key":"R8-20260629","doi-asserted-by":"crossref","first-page":"427","DOI":"10.25259\/IJDVL_726_19","article-title":"A cross-sectional study of metabolic syndrome in patients with alopecia areata","volume":"87","author":"Nasimi","year":"2021","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R9-20260629","doi-asserted-by":"crossref","first-page":"e0268086","DOI":"10.1371\/journal.pone.0268086","article-title":"Lipocalin-2 and insulin as new biomarkers of alopecia areata","volume":"17","author":"Wa\u015bkiel-Burnat","year":"2022","journal-title":"PLoS One"},{"key":"R10-20260629","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5830\/CVJA-2010-070","article-title":"Prevalence of the metabolic syndrome in people of Asian Indian origin: outcomes by definitions","volume":"22","author":"Das","year":"2011","journal-title":"Cardiovasc J Afr"},{"key":"R11-20260629","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnut.2020.00031","article-title":"Metabolic syndrome and insulin resistance in schoolchildren from a developing country","volume":"7","author":"Das","year":"2020","journal-title":"Front Nutr"},{"key":"R12-20260629","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines\u2014Part II","volume":"51","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R13-20260629","first-page":"593","article-title":"Markers of venous thromboembolism risk in patients with alopecia areata","volume":"315","author":"Wa\u015bkiel-Burnat","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"R14-20260629","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/0971-5916.166582","article-title":"High sensitivity C-reactive protein (hsCRP) and cardiovascular disease: An Indian perspective","volume":"142","author":"Kamath","year":"2015","journal-title":"Indian J Med Res"},{"key":"R15-20260629","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.atherosclerosis.2011.10.031","article-title":"Elevated levels of C-reactive protein as a risk factor for metabolic syndrome in Indians","volume":"220","author":"Mahajan","year":"2012","journal-title":"Atherosclerosis"},{"key":"R16-20260629","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.3390\/jcm13154361","article-title":"Psoriasis and lupus erythematosus-Similarities and differences between two autoimmune diseases","volume":"13","author":"Fija\u0142kowska","year":"2024","journal-title":"J Clin Med"},{"key":"R17-20260629","doi-asserted-by":"crossref","first-page":"10402","DOI":"10.3390\/ijms221910402","article-title":"Psoriasis and atherosclerosis-Skin, joints, and cardiovascular story of two plaques in relation to the treatment with biologics","volume":"22","author":"Wierzbowska-Drabik","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R18-20260629","first-page":"928030","article-title":"Cytokines and other mediators in alopecia areata","author":"Gregoriou","year":"2010","journal-title":"Mediators Inflamm 2010"},{"key":"R19-20260629","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2141.2001.03061.x","article-title":"Interleukin 6 and haemostasis","volume":"115","author":"Kerr","year":"2001","journal-title":"Br J Haematol"},{"key":"R20-20260629","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.15419\/bmrat.v8i10.702","article-title":"Evaluation of serum levels of IL-6, IL-10, and TNF-\u03b1 in alopecia areata patients: A systematic review and meta-analysis","volume":"8","author":"Torkestani","year":"2021","journal-title":"Biomed Res Ther"},{"key":"R21-20260629","first-page":"43","article-title":"Oxidative stress and alopecia areata","volume":"8","author":"Prie","year":"2015","journal-title":"J Med Life"},{"key":"R22-20260629","doi-asserted-by":"crossref","first-page":"1181572","DOI":"10.3389\/fmed.2023.1181572","article-title":"Oxidative stress and alopecia areata","volume":"10","author":"Ma","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"(Suppl 1)","key":"R23-20260629","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/rheumatology\/key432","article-title":"Janus kinases to jakinibs: From basic insights to clinical practice","volume":"58","author":"Gadina","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R24-20260629","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jamadermatol.2020.1133","article-title":"Time-dependent risk of acute myocardial infarction in patients with alopecia areata in Korea","volume":"156","author":"Shin","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R25-20260629","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s13555-023-00971-7","article-title":"Markers of venous thromboembolism risk in patients with alopecia areata: Is there anything to worry about?","volume":"13","author":"Wa\u015bkiel-Burnat","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"R26-20260629","doi-asserted-by":"crossref","first-page":"955035","DOI":"10.3389\/fimmu.2022.955035","article-title":"An overview of JAK\/STAT pathways and JAK inhibition in alopecia areata","volume":"13","author":"Lensing","year":"2022","journal-title":"Front Immunol"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_352_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:29:59Z","timestamp":1787768999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_352_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_352_25","relation":{},"ISSN":["2229-5178","2249-5673"],"issn-type":[{"value":"2229-5178","type":"print"},{"value":"2249-5673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"2025-03-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}